Breast Cancer Stage III Clinical Trial
Official title:
Radiotherapy Dose Adaptation Based on Tumor Biology in Patients With cN2b-N3 Breast Cancer: Non-randomized Phase II, Prospective Single Arm Study Clinical Trial
The purpose of the study is to evaluate treatment outcomes of breast cancer with internal mammary or supraclavicular lymph node metastasis according to total radiation dose of postoperative radiation therapy differentiated by tumor response to neoadjuvant chemotherapy. The main questions it aims to answer are: - 5-year disease-free survival - 5-year overall survival - 5-year locoregional recurrence - Adverse events after radiation therapy - Quality of life Participants will be assessed by multi-dimensional methods before and after radiotherapy: - Disease status evaluation including physical and radiological examination - Quality of life assessment with questionnaires (BREAST-Q) - Adverse event assessment according to CTCAE version 5.0
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05528263 -
Preventing Chemotherapy-Induced Peripheral Neuropathy With Acupuncture (PACT Trial)
|
N/A | |
| Recruiting |
NCT03270072 -
The Differential Impact of Proton Beam Irradiation Versus Conventional Radiation on Organs-at-risk in Stage II-III Breast Cancer Patients
|
||
| Terminated |
NCT03723863 -
Occupational Therapist-Led Work Intervention in Facilitating Work Maintenance or Re-entry to the Workforce in Patients With Stage I to III Breast Cancer Undergoing Chemotherapy
|
N/A | |
| Active, not recruiting |
NCT04180579 -
Safety of Lower Scalp Cooling Temperature to Prevent Hair Loss From Chemotherapy in Breast Cancer Patients
|
N/A | |
| Recruiting |
NCT03879577 -
Assessing the Response Rate of Neo-adjuvant Taxotere and Trastuzumab in Nigerian Women With Breast Cancer
|
Phase 2 | |
| Withdrawn |
NCT03058939 -
Assessing the Response Rate of Neo-adjuvant Paclitaxel (Taxol) in Nigerian Women With Breast Cancer
|
Phase 2 | |
| Recruiting |
NCT05877859 -
Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab
|
||
| Withdrawn |
NCT05774886 -
Implantable Microdevice for TNBC - Pilot Study
|
Phase 1 | |
| Unknown status |
NCT01352494 -
Neoadjuvant Chemotherapy With Docetaxel and Gemcitabine in Locally Advanced Breast Cancer
|
Phase 2 | |
| Completed |
NCT03578627 -
Stress and Immunity Breast Cancer Project
|
N/A | |
| Recruiting |
NCT06275126 -
Optimizing Surgical Decisions in Young Adults With Breast Cancer
|
N/A | |
| Active, not recruiting |
NCT03766009 -
Increasing Patients' Engagement in Breast Cancer Surgery Decision-Making
|
N/A | |
| Recruiting |
NCT05406531 -
The Effectiveness of Psychological Interventions in Psycho-neuroendocrine-immune Network in Breast Cancer Survivors
|
N/A | |
| Active, not recruiting |
NCT03609047 -
Adjuvant Palbociclib in Elderly Patients With Breast Cancer
|
Phase 2 | |
| Recruiting |
NCT06006806 -
Evaluation of Radiobiological Effects in Skin Toxicities for Breast Cancer Patients With Pencil Beam Scanning Proton Therapy
|
N/A | |
| Recruiting |
NCT05898789 -
Virtual Rehabilitation for Cancer Survivors
|
N/A | |
| Active, not recruiting |
NCT03927027 -
Axillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node Dissection
|
Phase 3 | |
| Recruiting |
NCT05288777 -
Adjuvant Chemoradiation and Biomarkers of Response in High-risk Breast Cancer
|
Phase 2/Phase 3 | |
| Not yet recruiting |
NCT06336538 -
Abbreviated MBCT for Depression in Older African American/Black Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT05828238 -
Positron Emission Tomograph(PET) Imaging Explores the Role of SF-DEVD-2 in Monitoring Tumor Efficacy
|
Early Phase 1 |